What can Biobanks Learn From the Current Pandemic?
More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a …
More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a …
The new SARS-CoV-2 emerged as a worldwide pandemic in late 2019. It is causing an infectious disease known as COVID-19, with a wide and diverse range of symptoms. In most …
Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. We hope you will find this enriching and useful. Please do let us know your …
Nearly every second individual is affected by a mental health problem in their lifetime, but the exact mechanisms causing these problems remain unclear. To bring more clarity to the field …
Ovarian cancer is the leading cause of gynecological-related mortality. High-grade serous ovarian carcinoma (HGSOC), the most prevalent subtype, develops rapidly and is rarely diagnosed before the advanced-stage disease. Treatment options are limited and survival rates have …
As research into genetic causes of disease began to grow, Le Bonheur Pediatrician-in- Chief Jon McCullers, MD, knew it was time to start building a pediatric DNA biorepository. So in …
Vets across the UK are being asked to help develop a national equine grass sickness (EGS) sample biobank and database. The Moredun Foundation Equine Grass Sickness Fund has launched a …
The University of Saskatchewan has been awarded $6.76 million from the Canada Foundation for Innovation to help conserve bison and other threatened animal species and address challenges facing the beef …
Well-annotated, high-quality biorepositories provide a valuable platform to support translational research. However, most biorepositories have poor representation of minority groups, limiting the ability to address health disparities. This paper describes …
The United States has announced that it will spend big on research into ‘long COVID’ — the long-lasting health effects of a SARS-CoV-2 infection. The National Institutes of Health will fund …